| Metric | შპს სისხლის ბანკი | შპს გენომიქსი | შპს მედლაბ 2024 |
|---|---|---|---|
| Growth | |||
| Revenue | ₾1.4m | ₾1.3m | ₾1.8m |
| Revenue growth | — | — | — |
| Profitability | |||
| EBITDA | ₾29k | -₾304k | ₾582k |
| EBITDA margin | 2.1% | -22.9% | 33.0% |
| Net profit | -₾33k | -₾277k | ₾586k |
| Net margin | -2.3% | -20.9% | 33.2% |
| Balance sheet | |||
| Total assets | ₾1.9m | ₾2.6m | ₾1.3m |
| Total equity | ₾1.8m | ₾1.2m | ₾586k |
| ROE | -1.8% | -23.2% | 100.0% |